BCM
CELG

BlueCrest Capital Management’s Celgene Corp CELG Stock Holding History

BlueCrest Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-68,843
Closed -$6.84M – 714
2019
Q3 		$6.84M Buy
68,843
+13,034
+23% +$1.24M 0.47% 47
2019
Q2 		$5.16M Sell
55,809
-18,661
-25% -$1.77M 0.37% 54
2019
Q1 		$7.03M Buy
+74,470
New +$6.51M 0.28% 50
2018
Q4 		– Sell
-24,555
Closed -$2.2M – 1755
2018
Q3 		$2.2M Sell
24,555
-174,924
-88% -$15.5M 0.06% 241
2018
Q2 		$15.8M Buy
199,479
+108,263
+119% +$8.99M 0.41% 32
2018
Q1 		$8.14M Buy
+91,216
New +$8.76M 0.25% 69
2017
Q1 		– Sell
-14,921
Closed -$1.73M – 1045
2016
Q4 		$1.73M Buy
+14,921
New +$1.66M 0.09% 280
2016
Q3 		– Sell
-6,399
Closed -$631K – 1131
2016
Q2 		$631K Buy
+6,399
New +$662K 0.03% 459
2015
Q3 		– Sell
-2,155
Closed -$249K – 1177
2015
Q2 		$249K Sell
2,155
-312
-13% -$35.7K 0.01% 740
2015
Q1 		$284K Sell
2,467
-811
-25% -$96.9K 0.02% 531
2014
Q4 		$367K Buy
+3,278
New +$346K 0.01% 479

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

BlueCrest Capital Management's CELG Position: Q4 2019 in Review

BlueCrest Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 68,843 shares — an estimated $6.84M sold.

BlueCrest Capital Management first reported a position in CELG in Q4 2014 and held it in 11 quarters. The position peaked at $15.8M in Q2 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • BlueCrest Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 68,843 Celgene Corp shares in Q4 2019, an estimated $6.84M.
  • BlueCrest Capital Management first reported a position in Celgene Corp in Q4 2014 and held it in 11 quarters.
  • BlueCrest Capital Management's Celgene Corp position peaked at $15.8M in Q2 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on BlueCrest Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.